Liver conditions
Every manufacturer places this the same way.
scroll for all 10 products →
| Section | Brown & Burk UK Ltd10mg Tablets | Strides Pharma UK Ltd10mg Tablets | Flamingo Pharma (UK) Ltd10mg Tablets | Wockhardt UK Ltd10mg/5ml Oral Solution | Flamingo Pharma (UK) Ltd25mg Tablets | Wockhardt UK Ltd25mg/5ml Oral Solution | Wockhardt UK Ltd50mg/5ml Oral Solution | Rosemont Pharmaceuticals Limited50mg/5ml Oral Solution | Amarox Limited10mg Tablets | SyriMed10mg/5ml Oral Solution |
|---|---|---|---|---|---|---|---|---|---|---|
| ContraindicatedThe label says it must not be used. | Contraindicated | Contraindicated | Contraindicated | Contraindicated | Contraindicated | Contraindicated | Contraindicated | Contraindicated | Contraindicated | Contraindicated |
| WarningThe label says it can be used, with care. | ||||||||||
| InteractionThe label says another medicine affects it. | ||||||||||
| PregnancyThe label gives advice for pregnancy or breastfeeding. | ||||||||||
| ExcipientThe label lists it as an ingredient, not a restriction. |
- Contraindicated
786–807 of 842 characters 785–806 of 841 characters 785–806 of 841 characters 784–805 of 840 characters 785–806 of 841 characters 784–805 of 840 characters 784–805 of 840 characters Rosemont Pharmaceuticals Limited
787–808 of 844 characters 806–827 of 866 characters 785–806 of 841 characters
n of irreversible non- selective MAOIs and minimum one day after discontinuation of the reversible moclobemide. Treatment with MAOIs may be introduced 14 days after discontinuation of amitriptyline. Severe liver disease. In children under 6 years of age.
Identical in all 10 labels. Surrounding text shown from Brown & Burk UK Ltd.